SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia

Stéphanie Poulain1, Marjan Ertault, Xavier Leleu

  • 1Service d'Hématologie-Immunologie-Cytogénétique, Centre Hospitalier de Valenciennes, Valenciennes, France. poulain-s@ch-valenciennes.fr

Leukemia Research
|April 28, 2009
PubMed